Boston Scientific Corp (MIL:1BSX)
€ 85.5 0 (0%) Market Cap: 126.98 Bil Enterprise Value: 135.61 Bil PE Ratio: 74.26 PB Ratio: 6.39 GF Score: 56/100

Boston Scientific Corp at Cowen Healthcare Conference (Virtual) Transcript

Mar 01, 2021 / 07:00PM GMT
Joshua Thomas Jennings;Meghan Scanlon
Cowen and Company, LLC, Research Division - MD & Senior Research Analyst;Boston Scientific Corporation -

Good afternoon. I'm Josh Jennings, from the medical device team at Cowen, along with Bryan Kennedy, Neil Chatterji and Eric Anderson. We're thrilled to get you on the afternoon track with Boston Scientific. It's usually an easy ask to have them travel just down the road when we host a conference live in Boston. And this year, it's virtual, but we're still very happy and appreciative of Boston joining the Cowen Health Care Conference once again.

We have an executive from Urology and Pelvic Health division, Meghan Scanlon, Senior Vice President and President; along with Susie Lisa, Vice President of Investor Relations. And I think the Urology and Pelvic Health franchise doesn't get as much attention as it should considering the performance over the past 3 to 4 years. So we're really excited to dig into the business, Meghan. Thanks so much for being here, both you and Susie. And I can just start to dig in, if that's okay.

Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis
30-Year Financial on one screen
All-in-one Stock Screener with unlimited filters
Customizable Stock Dashboard
Real Time Insider Trading Transactions
8,000+ Institutional investors’ 13F holdings
Powerful Excel Add-in and Google sheets Add-on
All data downloadable
Quick customer support
And much more...
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot